Preferred Osteoporosis Model, which has excellent quality,PharmaLegacy_specification/price/image

Product Detail
Company Profile

PharmaLegacy Laboratories (Shanghai) Co., Ltd is a professional company inAutoimmuneDiseasesModel,Liver Fibrosis Modelx2a38631n. Since its inception,with innovative technology,advanced management,high-quality service,we won the majority of customer recognition.The companys core values are:either do not do,or do Rheumatoid arthritis Model service really well

PharmaLegacy Laboratories (Shanghai) Co., Ltd have Decades of professional field Osteoporosis Model,Osteoporosis Model the measures,Osteoporosis Model good service business,Osteoporosis Model the basic characteristics,Osteoporosis Model the main features,Osteoporosis Model the quality and other areas of expertise, combined with excellent service capabilities, To provide customers with professional, customized Osteoporosis Model. Moreover, since the establishment of a long time ago,the Osteoarthritis Modelbusiness of PharmaLegacy has always maintained a high-speed and stable growth. details: Bone provides protection to visceral organs, storage of minerals, locomotive movement and are the locations of hematopoiesis. Structural integrity of bone can be affected by factors of aging, dietary imbalance, disuse, environmental contamination, infections, medicine, metabolic disorders, physical loading, radiation, smoking and trauma. Efficacy and safety data of the developing therapeutics to osteoporosis model is required to predict the effects in human for excluding the toxicity of it. Bone fragility increases with age in both genders, and most notably after menopause in female. Anti-resorptive agents are well established, such as bisphosphonates, SERMs and likely anti-RANKL antibodies. Anabolic agents are actively being developed. Besides PTH analogues and stem cells, molecules from BMP family and Wnt signal pathways, such as Smads, ERK, Dkk-1, Runx2, and beta-catenin are targets for therapeutics. Safety and efficacy data of osteoporosis model (rodents and non-human primates) are required to predict the therapeutic effects in human.

The integrity, strength and prodzationuct quality of PharmaLegacy Laboratories (Shanghai) Co., Ltdhas gain highly industry recognition. Welcome friends from all walks of life come for visit, guidance and business negotiations. For more information please visit: www.pharmalegacy.com

PharmaLegacy Laboratories is a leading speciality pharmacology Contract Research Organization located in Shanghai Zhangjiang High-Tech Park, China. PharmaLegacy is equipped with a world-class facility, working to international pharmaceutical industrial standards. PharmaLegacy provides preclinical in vivo pharmacology efficacy services as well a therapeutic antibody discovery service program. Our state-of-the-art platforms include:· Pioneering work using CD34+ humanized mice that carry a human immune system, to test biologics for immuno-oncology therapeutic efficacy· An NHP platform for therapeutic biologics testing in a variety of immune diseases · An advanced antibody discovery platform based on single B cell antibody sequencing · An internationally recognized Bone/Orthopaedics platform to test both hard tissue disease therapeutic candidates and medical devicesPharmaLegacy offers a full range of preclinical pharmacology services for evaluating pharmacological effects of drug candidates in the areas of inflammation/auto-Immune diseases, lung injury, liver/metabolic diseases and oncology. Our NHP platform and CD34+ humanized mice models have helped dozens of clients with IND filings